CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigator Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0672

Test Propionate

Filed under Injectable Oils. The bureau holds 135 laboratory returns for this compound from 44 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

44 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
Tianjin Finder Chemical TFCCASE #VI-2026-0693 A 6 10.0 9.9 10.0 14 Nov 2025 16 Apr 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936 A 4 10.0 9.9 10.0 18 May 2026 27 Jun 2026
Sangon BioCASE #VI-2026-0671 A 4 10.0 10.0 10.0 10 Feb 2026 12 Jun 2026
JEEP PeptidesCASE #VI-2026-0457 A 4 10.0 10.0 10.0 1 Apr 2026 8 Jul 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379 A 4 10.0 9.9 10.0 11 Feb 2026 11 Jul 2026
Shanghai Sigma AudleyCASE #VI-2026-0505 A 4 10.0 9.9 10.0 13 Jan 2026 9 Jun 2026
AsymchemCASE #VI-2026-0091 A 4 10.0 10.0 10.0 25 Feb 2026 12 Jul 2026
Mokemei BiotechnologyCASE #VI-2026-0540 A 3 10.0 10.0 10.0 14 Apr 2026 12 May 2026
SinoPepCASE #VI-2026-0387 A 3 10.0 9.9 10.0 26 Mar 2026 19 Aug 2026
AmbioPharmCASE #VI-2026-0177 A 3 10.0 9.9 10.0 27 Dec 2025 19 Jul 2026
QYAOBIOCASE #VI-2026-0861 A 2 10.0 10.0 10.0 5 Jun 2026 10 Jun 2026
Kerui PeptidesCASE #VI-2026-0626 A 2 10.0 10.0 10.0 5 Feb 2026 24 Jun 2026
Flourishglobal PeptideCASE #VI-2026-0630 A 2 10.0 10.0 10.0 10 Mar 2026 15 Jul 2026
Hybio PharmaceuticalCASE #VI-2026-0065 A 2 10.0 10.0 10.0 26 Mar 2026 19 Jul 2026
Sigma-AldrichCASE #VI-2026-0829 A 2 10.0 10.0 10.0 19 Jun 2026 16 Aug 2026
PeptidologyCASE #VI-2026-0520 X 1 10.0 10.0 10.0 2 Jul 2025 2 Jul 2025
HomopeptideCASE #VI-2026-0760 A 7 9.9 9.9 10.0 24 May 2026 24 May 2026
WuXi TIDESCASE #VI-2026-0335 A 5 9.9 9.9 10.0 22 Apr 2026 1 Jul 2026
PolyPeptide GroupCASE #VI-2026-0143 A 4 9.9 9.9 10.0 19 Dec 2025 18 Jul 2026
BachemCASE #VI-2026-0314 A 2 9.9 9.9 9.9 13 Dec 2025 6 Jan 2026
Hubei JianxiangCASE #VI-2026-0048 A 2 9.9 9.9 10.0 27 Feb 2026 16 Mar 2026
Chinese Peptide CompanyCASE #VI-2026-0184 A 2 9.9 9.9 10.0 9 Apr 2026 24 Jun 2026
GenScript PeptidesCASE #VI-2026-0860 A 2 9.9 9.9 10.0 5 Jan 2026 15 May 2026
Thermo Fisher ScientificCASE #VI-2026-0142 A 2 9.9 9.9 10.0 23 May 2026 7 Jun 2026
PeptiSlimCASE #VI-2026-0557 X 1 9.3 9.3 9.3 11 Jun 2025 11 Jun 2025
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 A 8 8.7 7.2 10.0 21 May 2026 21 May 2026
NextGen HealthCASE #VI-2026-0604 X 1 8.7 8.7 8.7 2 Apr 2025 2 Apr 2025
Qingdao Sigma Chemical QSCCASE #VI-2026-0538 A 7 8.6 7.6 9.4 23 May 2026 23 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486 A 5 8.6 7.8 9.4 24 May 2026 24 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 A 2 8.6 8.1 9.0 24 May 2026 24 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704 A 2 8.3 7.5 9.1 24 May 2026 24 May 2026
ZhuoYan labCASE #VI-2026-0902 X 3 7.3 5.8 8.4 27 Feb 2025 24 May 2026
PeptiLab ResearchCASE #VI-2026-0267 X 1 7.3 7.3 7.3 24 Apr 2025 24 Apr 2025
Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 X 1 7.3 7.3 7.3 27 Feb 2025 27 Feb 2025
LSPLCASE #VI-2026-0523 X 4 7.2 6.2 8.8 3 Jun 2025 23 May 2026
Qingdao Hongshengda TradingCASE #VI-2026-0334 X 1 7.1 7.1 7.1 20 Jun 2025 20 Jun 2025
HkRoidsCASE #VI-2026-0784 X 1 7.1 7.1 7.1 14 Jan 2025 14 Jan 2025
Yabang PeptideCASE #VI-2026-0148 X 1 7.0 7.0 7.0 17 Dec 2024 17 Dec 2024
OupeptideCASE #VI-2026-0435 X 14 6.9 4.0 9.0 16 Mar 2025 26 Jan 2026
Astro PeptidesCASE #VI-2026-0424 X 2 6.8 6.0 7.7 2 Jul 2025 21 May 2026
Haikou Mingheng BiotechnologyCASE #VI-2026-0126 X 1 4.8 4.8 4.8 2 Apr 2025 2 Apr 2025
DeuschemCASE #VI-2026-0004 X 2 3.5 2.6 4.4 6 May 2025 25 May 2026
Evolve BioPepCASE #VI-2026-0755 X 1 3.1 3.1 3.1 7 May 2025 7 May 2025
PepKitsCASE #VI-2026-0320 X 1 0.0 0.0 0.0 20 Jun 2025 20 Jun 2025

Open any subject to view the batch-level evidence for Test Propionate alone.